These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 32014610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer.
    Nindra U, Pal A, Bray V, Yip PY, Tognela A, Roberts TL, Becker TM, Williamson J, Farzin M, Li JJ, Lea V, Hagelamin A, Ng W, Wang B, Lee CS, Chua W.
    Intern Med J; 2024 Apr; 54(4):596-601. PubMed ID: 37713593
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma.
    Brisudova A, Skarda J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):127-132. PubMed ID: 32284620
    [Abstract] [Full Text] [Related]

  • 9. Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
    Volckmar AL, Leichsenring J, Kirchner M, Christopoulos P, Neumann O, Budczies J, Morais de Oliveira CM, Rempel E, Buchhalter I, Brandt R, Allgäuer M, Talla SB, von Winterfeld M, Herpel E, Goeppert B, Lier A, Winter H, Brummer T, Fröhling S, Faehling M, Fischer JR, Heußel CP, Herth F, Lasitschka F, Schirmacher P, Thomas M, Endris V, Penzel R, Stenzinger A.
    Int J Cancer; 2019 Aug 01; 145(3):649-661. PubMed ID: 30653256
    [Abstract] [Full Text] [Related]

  • 10. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F, Zheng X, Mao X, Zhao R, Ye J, Zhang Y, Sun J.
    Ann Thorac Surg; 2019 Jul 01; 108(1):219-226. PubMed ID: 30885850
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experience.
    Dall'Olio FG, Conci N, Rossi G, Fiorentino M, De Giglio A, Grilli G, Altimari A, Gruppioni E, Filippini DM, Di Federico A, Nuvola G, Ardizzoni A.
    Lung Cancer; 2020 Nov 01; 149():5-9. PubMed ID: 32932213
    [Abstract] [Full Text] [Related]

  • 14. Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.
    Garinet S, Lupo A, Denize T, Loyaux R, Timsit S, Gazeau B, Fabre E, Maaradji Z, Gibault L, Giroux-Leprieur E, Duchemann B, Monnet I, Jouveshomme S, Aldea M, Besse B, Le Pimpec-Barthes F, Leroy K, Wislez M, Blons H.
    Pathology; 2024 Aug 01; 56(5):702-709. PubMed ID: 38834439
    [Abstract] [Full Text] [Related]

  • 15. RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer.
    Radonic T, Geurts-Giele WRR, Samsom KG, Roemen GMJM, von der Thüsen JH, Thunnissen E, Meijssen IC, Sleddens HFBM, Dinjens WNM, Boelens MC, Weijers K, Speel EJM, Finn SP, O'Brien C, van Wezel T, Cohen D, Monkhorst K, Roepman P, Dubbink HJ.
    J Thorac Oncol; 2021 May 01; 16(5):798-806. PubMed ID: 33588111
    [Abstract] [Full Text] [Related]

  • 16. Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
    Kim EK, Kim KA, Lee CY, Kim S, Chang S, Cho BC, Shim HS.
    Clin Lung Cancer; 2019 Jan 01; 20(1):e123-e132. PubMed ID: 30391211
    [Abstract] [Full Text] [Related]

  • 17. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
    Claerhout S, Lehnert S, Vander Borght S, Spans L, Dooms C, Wauters E, Vansteenkiste J, Weynand B, Deraedt K, Bourgain C, Vanden Bempt I.
    Lung Cancer; 2022 Apr 01; 166():242-249. PubMed ID: 35378489
    [Abstract] [Full Text] [Related]

  • 18. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
    Ju S, Cui Z, Hong Y, Wang X, Mu W, Xie Z, Zeng X, Su L, Lin X, Zhang Z, Zhang Q, Song X, You S, Chen R, Chen W, Xu C, Zhao J.
    Cancer; 2023 Aug 01; 129(15):2422-2430. PubMed ID: 37096747
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D, Zhang D, Chen K, Lu J, Wu J, Cao X, Ying L, Jin Q, Ye Y, Xie Z, Xiong L, Mao W, Li F.
    J Exp Clin Cancer Res; 2017 Sep 07; 36(1):121. PubMed ID: 28882180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.